Kristian Reich

Kristian Reich

Company: MoonLake Immunotherapeutics

Job title: Founder & Chief Scientific Officer


Spearheading a Novel Drug Candidate in Chronic Inflammatory Skin and Joint Diseases 11:30 am

Outlining the emerging story of IL-17A and F in inflammatory diseases How to Optimize targeting an important cytokine pathway – MOA and unique molecule characteristics of the novel IL-17 drug candidate sonelokimab Showcasing disease control by sonelokimab from a phase 2b trial in psoriasis Broadening the spectrum – Preparing for success in HS and PsARead more

day: Day 1 AM - Track B

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.